NASDAQ · TRNS
Industrials · Specialty Business Services
$84.31▲ 2.37% ($1.95)today
As of 4:00 PM ET
Market cap
$789.13M
P/E
231.77
Volume
98.08K
Shares outstanding
9.36M
To support a price of $84.31, this model requires revenue to grow by 31.56%/yr over the next 10 years, compounded annually.
Historical revenue grew by 12.8%/yr over the past 4 years. The required annual growth rate is 18.75 percentage points higher.
Selected forecast · Base scenario
9.75%/yr · actual 10-year annualized revenue growth
Year 1 growth: 15.28%
Market-implied · Base operating assumptions + edited margins
31.56%/yr · flat 10-year annualized revenue growth
Reverse DCF solves revenue growth itself using Base operating assumptions and your edited margins. Changing forecast growth alone does not change the implied rate. This is a model-implied requirement, not an analyst forecast.
Price used
$84.31
Estimated value / share
$12.42
Base scenario
This estimate is 85.26% below the price used.
Year 1 growth 15.28% · Ending margin 3.02% · Discount rate 8.09%
Assumption scenarios, not statistical confidence intervals.
Estimated from future revenue, operating margins, and the investment needed to support them.
FCFF is positive, but the series is too unstable to anchor a direct cash-flow CAGR and the business still fails the steady-state comparability checks. Use a revenue-and-margin transition model instead of normalizing and compounding current FCFF.
Is FCFF positive and has it been for 3+ consecutive years? 11 consecutive positive FCFF years are available.
Is FCFF stable (not swinging >30% year to year)? The largest recent FCFF swing is 166.1%.
Do you have 5+ years of positive FCFF history? 11 consecutive positive FCFF years are available.
Is the business model structurally similar to what it should be in 10 years? Revenue is still growing 20.5%, above the 15.0% maturity threshold, so a steady-state FCFF model would lean too heavily on a business still scaling.
TRNS
Price vs Fundamentals
The stock rose 10.34% over the last year. Revenue grew 20.17% over the trailing twelve months. Operating margin moved from 7.36% to 3.02%. Free cash flow grew 29.51% over the trailing twelve months.
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
Operating margin currently stands at 3.02%. A decisive move in revenue — currently up 20.17% — would be the clearest signal to resolve the ambiguity.
Performance
Company profile
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation.
Market multiples
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
8
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 2, 2026
Q4 FY26 · EPS est $0.41 · Revenue est $92.42M
View